Stock PLX PROTALIX BIOTHERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Protalix BioTherapeutics, Inc.

Equities

PLX

US74365A3095

Delayed Nyse
Other stock markets
 03:58:20 2024-06-05 pm EDT 		5-day change 1st Jan Change
1.15 USD +1.77% Intraday chart for Protalix BioTherapeutics, Inc. +3.57% -34.83%
May. 10 Transcript : Protalix BioTherapeutics, Inc., Q1 2024 Earnings Call, May 10, 2024
May. 10 Protalix BioTherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
HC Wainwright Adjusts Protalix BioTherapeutics' Price Target to $10 From $7, Keeps Buy Rating
MT
PROTALIX BIOTHERAPEUTICS : HC Wainwright Adjusts Price Target on Protalix BioTherapeutics to $7 From $11, Maintains Buy Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PLX Stock
  4. News Protalix BioTherapeutics, Inc.
  5. Analyst Reco.